COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

Search

Hims & Hers Health Inc

Closed

SectorConsumer defensive

16.63 -3.48

Overview

Share price change

24h

Current

Min

16.63

Max

17.61

Key metrics

By Trading Economics

Income

-27M

16M

Sales

54M

599M

P/E

Sector Avg

36.472

33.023

Profit margin

2.633

Employees

1,637

EBITDA

-7.3M

30M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+70.46% upside

Dividends

By Dow Jones

Next Earnings

23 Feb 2026

Market Stats

By TradingEconomics

Market Cap

-5.6B

4.4B

Previous open

20.11

Previous close

16.63

News Sentiment

By Acuity

100%

0%

124 / 133 Consumer defensive

Technical Score

By Trading Central

Confidence

Bullish Evidence

Hims & Hers Health Inc Chart

Past performance is not a reliable indicator of future results.

Related News

9 Feb 2026, 09:37 UTC

Major Market Movers

Novo Nordisk Shares Jump After Hims & Hers Scraps Plan For Copycat Weight-Loss Pill

5 Aug 2025, 00:05 UTC

Hot Stocks

Stocks to Watch: Palantir Technologies, Hims & Hers Health, Vertex Pharmaceuticals, Kyndryl

29 Apr 2025, 12:54 UTC

Major Market Movers

Hims & Hers Rallies After Novo Nordisk Deal on Wegovy

4 Apr 2025, 22:38 UTC

Hot Stocks

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

1 Apr 2025, 23:15 UTC

Major Market Movers

Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings -- 2nd Update

25 Feb 2025, 15:33 UTC

Major Market Movers

Novo Nordisk Shares Rise as Hims & Hers to Stop Mimicking Weight-Loss Drugs

9 Feb 2026, 17:41 UTC

Earnings
Acquisitions, Mergers, Takeovers

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

9 Feb 2026, 17:31 UTC

Earnings
Acquisitions, Mergers, Takeovers

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

9 Feb 2026, 15:15 UTC

Earnings

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Valaris, Monday.com, Cleveland-Cliffs, and More -- Barrons.com

9 Feb 2026, 15:07 UTC

Hot Stocks

Stocks to Watch Monday: Novo Nordisk, Hims & Hers, Apollo -- WSJ

9 Feb 2026, 13:13 UTC

Earnings

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Kroger, Nvidia, Monday.com, and More -- Barrons.com

2 Nov 2025, 10:30 UTC

Acquisitions, Mergers, Takeovers

Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk -- Heard on the Street -- WSJ

22 Oct 2025, 21:25 UTC

Earnings

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

5 Aug 2025, 20:44 UTC

Earnings

These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 Aug 2025, 18:17 UTC

Earnings

These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More -- Barrons.com

5 Aug 2025, 17:26 UTC

Earnings
Acquisitions, Mergers, Takeovers

Hims & Hers Had a Tough Quarter. Weight-Loss Drugs Are Only One Problem. -- Barrons.com

5 Aug 2025, 15:25 UTC

Earnings

Correction to These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, Caterpillar, BP, and More -- Barrons.com

5 Aug 2025, 11:27 UTC

Earnings

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 Aug 2025, 10:55 UTC

Earnings

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

5 Aug 2025, 10:36 UTC

Earnings

Update: These Stocks Are Moving the Most Today: Palantir, Vertex, Hims & Hers, AMD, BP, and More -- Barrons.com

29 Jul 2025, 16:55 UTC

Earnings

The Obesity Bubble Has Finally Burst. Novo Nordisk Shares Drop 21%. -- Barrons.com

24 Jun 2025, 10:26 UTC

Market Talk

Novo Nordisk Sends Clear Message on Copycat Drugs -- Market Talk

3 Jun 2025, 15:03 UTC

Acquisitions, Mergers, Takeovers

Hims & Hers Seeks Growth in Europe as Weight-Loss Business Shifts -- Barrons.com

7 May 2025, 13:56 UTC

Earnings

Novo Nordisk Stock Jumps After Earnings. Compounding Market's Growth Took it By Surprise -- Barrons.com

6 May 2025, 14:24 UTC

Earnings

Hims & Hers Stock Is Higher After Earnings. The Sales Outlook Looks Low. -- Barrons.com

30 Apr 2025, 09:30 UTC

Top News

Why New Wegovy Deals Won't Restore Novo's Obesity Lead -- Heard on the Street -- WSJ

2 Apr 2025, 16:53 UTC

Top News

Hims & Hers Zepbound Offering Won't Bring Needed Sales Boom -- Analysis

19 Mar 2025, 15:54 UTC

Top News

Sale of Ozempic Knockoffs Are Supposed to End Soon. Telehealth Companies Aren't Happy. -- WSJ

21 Feb 2025, 23:20 UTC

Earnings

These Stocks Moved the Most Today: UnitedHealth, Alibaba, Rivian, Celsius, Booking, Block, Akamai, Hims & Hers, and More -- Barrons.com

Peer Comparison

Price change

Hims & Hers Health Inc Forecast

Price Target

By TipRanks

70.46% upside

12 Months Forecast

Average 32.95 USD  70.46%

High 60 USD

Low 16.5 USD

Based on 12 Wall Street analysts offering 12 month price targets forHims & Hers Health Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

12 ratings

3

Buy

6

Hold

3

Sell

Technical Score

By Trading Central

36.685 / 52.35Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

124 / 133 Consumer defensive

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
help-icon Live chat